April 2026
1. PICHAT CSH, Ballegaard ELF, Bressendorff IO, Jorgensen HS, et al
   Parathyroid hormone and alkaline phosphatase are associated with fracture risk in non-dialysis-dependent chronic kidney disease.
   Osteoporos Int. 2026 Apr 22. doi: 10.1007/s00198-026-08035.
   

   >> Share

   
   
2. RASHID A, Hauge SC, Nielsen BR, Zerahn B, et al
   High prevalence of sarcopenia, osteoporosis and osteosarcopenia in patients with chronic kidney disease compared with healthy controls.
   Osteoporos Int. 2026 Apr 20. doi: 10.1007/s00198-026-08008.
   

   >> Share

   
   
3. DIZ LOPES M, Fassio A, Bianco B, Andreola S, et al
   Comparative longitudinal assessment of bone mineral density measured with radiofrequency echographic multi-spectrometry (REMS) and dual X-ray absorptiometry (DXA) in a cohort of peritoneal dialysis patients.
   Osteoporos Int. 2026 Apr 9. doi: 10.1007/s00198-026-07959.
   

   >> Share

   
   February 2026
4. BRAMPTON JJ, Harris BHL, Fertleman MB, Koizia LJ, et al
   High fracture risk, limited evidence: rethinking osteoporosis treatment in chronic kidney disease.
   Osteoporos Int. 2026 Feb 5. doi: 10.1007/s00198-026-07890.
   

   >> Share

   
   October 2025
5. ABDALBARY M, Amin AM, Elaraby A, Hassan A, et al
   Efficacy and safety of romosozumab in patients with chronic kidney disease and osteoporosis: a narrative review.
   Osteoporos Int. 2025 Oct 31. doi: 10.1007/s00198-025-07707.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share